Photosensitization of differentiating Friend erythroleukemic cells by hematoporphyrin derivative and the cholesterol effect

Pharmacokinetic and therapeutic outcome in melanoma cells, of the administration of symmetric and asymmetric cationic photosensitizers

The response of melanoma cell lines to a range of novel cationic photosensitizers based on either a protoporphyrin or a mesotetra(4-carboxylphenyl)porphine molecule, has been examined. The drugs varied in terms of either their symmetry or their side chain configuration. The effect of these variables on drug uptake and photodynamic cell kill were tested. The absorption wavelengths for the drugs were measured and a shift to the red was seen in the presence of cells. Drug uptake was measured and the cationic sensitizers had a relatively high uptake when compared to anionic HpD. The efficiency of the drugs in causing cell kill was expressed in terms of clonogenic cell survival. The asymmetric photosensitizers were more efficient in destroying mouse and human melanoma cells than the clinically used anionic HpD, which was in turn more efficient than the symmetric sensitizers tested.

Biological effects of photoactivated-HPD and cholesteryl hemisuccinate on erythroid differentiation

In order to establish the ability of porphyrins to distinguish between differentiated and undifferentiated cells of the erythropoietic pathway, the cytotoxic effects of hematoporphyrin derivative (HPD) on Friend erythroleukemic cells (FLC) were derivative (HPD) on Friend erythroleukemic cells (FLC) were studied. Since cholesterol affects the fluidity of cell membranes, the inhibitory effect of cholesteryl hemisuccinate (CHS) on HPD was similarly tested. FLC were induced with either dimethyl sulfoxide (DMSO), hemin, or both. The cells responded to DMSO-treatment by the synthesis of a large amount of hemoglobin and a decrease in both the cell volume and rate of cell-growth. Hemin, on the other hand, did not drive FLC to synthesize hemoglobin and reduced only moderately the growth rate compared to untreated cultures. The combined effect of DMSO and hemin led to a profound inhibition of the growth rate, but did not increase the synthesis of hemoglobin compared to the level observed in cells treated with DMSO only. The binding property of HPD to FLC was also determined. DMSO-treatment significantly reduced the amount of HPD-binding, and combined treatment with DMSO and hemin resulted in even a lower level of HPD-binding. On the other hand, induced as well as non-induced cells showed the same sensitivity to photoactivated HPD when both DNA and protein synthesis were examined. Pretreatment of both differentiated and undifferentiated cells with CHS reduced the cytotoxicity of photoactivated HPD to the same level. We conclude that the decreased binding of HPD to differentiated cells is a result of a reduction in their cell volume. Thus, the differentiation process per se does not protect cells against the photodynamic effect of HPD. Moreover, CHS may act as a scavenger or first acceptor of singlet oxygen blocking the photodynamic effect.

Bactericidal effects of photoactivated porphyrins--an alternative approach to antimicrobial drugs

Photoactivated porphyrins display a potent cytotoxic activity towards a variety of Gram positive bacteria, mycoplasma and yeasts, but not Gram negative cells. The prerequisite for photosensitization of a microbial cell is the binding of porphyrin to the cytoplasmic membrane in a pH-dependent manner. On illumination, the membrane bound, and possibly, cytoplasmic porphyrin molecules generate singlet oxygen and radicals which sensitize biomolecules and lead to cell death. The immediate inhibition of cell growth on photodynamic treatment is accompanied by alterations in cell wall and membrane synthesis, leading to the formation of large mesosomes adjacent to the unaccomplished septa. Hemin bound to microbial cells exerts cytotoxic activity by peroxidative and oxidative reactions independent of light. Future research in the field may enhance the possibility of using porphyrin photosensitization for treatment of microbial infections. Such clinical use will be unrelated to the antibiotic resistance of the pathogen. Resistance of Gram negative bacteria to porphyrin photosensitization is the main impediment to its use as a broad spectrum antibacterial method.